Error: Could not add to watchlist. X
+ Watchlist

Kane Biotech Inc

KNBID:US
Ticker Change
KNBID:US has changed to a new ticker symbol
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.09%
% Price Change
-0.13%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Kane Biotech Inc. is involved in the research and development of products to prevent and disperse bacterial biofilms. The Company's technology includes targets, methods, and processes involved in the formation of biofilms. Kane's technology has potential to improve the ability to prevent and/or destroy biofilms, in several medical and industrial applications.
Address
5-1250 Waverley Street
Winnipeg, MB R3T 6C6
Canada
Phone
1-204-453-1301
  • Mark Ahrens-Townsend
    President/CEO
Show More